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1. Introduction
Non-communicable diseases (NCDs) known to cause more than half of all deaths in sub
Saharan Africa over the past two decades has shown a steady increase to become a public
health concern,. [1-4]. More than 30% of these deaths are recorded before the age of 60 in the
resource poor countries. The mortality and morbidity caused by the NCDs is globally on the
increase. However, the greatest impact has been recorded in sub Saharan Africa where
healthcare facilities and medical awareness is low. In the developing countries NCDs is on the
rise at the same proportion with infectious diseases that has led to an increasing disease
burden, [2].
Other studies in sub-Saharan Africa has indicated that women within the ages of 15–49 are
dying from NCDs faster than the women living in high-income countries [3-4]. The burden of
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early mortality and disability poses a serious problem to socio economic and human devel‐
opment [3]. In countries where the public health systems are not well developed, payment for
health care service for the poor is difficult and creates more financial burden to the poor
subsistent population. The assess to treatment for metabolic disease such as diabetes has been
shown to cost a patient in some developing economies like India about 15-25% of their
household earnings [5-6]. Studies conducted by the World Bank showed that cardiovascular
disease can lead to high expenditure for about 25 % of India families and also creates poverty
to about 10 % of low income families [5-7]. The socio economic implication of population living
with NCDs ranges from time off work usually unpaid, high unemployment rate and also early
retirement from work. [6-8]. the world economic forum (WEF) based on socio economic
situation in developing economies attempts to place the NCDs among the top global concern
to economic empowerment [6-8].
Well-structured and coordinated primary prevention with elaborate health care disease
surveillance can potentially help reduce in developing countries like Africa [8].Base on the
good health care policy implementation strategies there has been a concerted effort by health
actors to develop and formulation of effective health programmes for the prevention and
potential control strategies for NCDs that was initiated during the World Health Assembly
that took place 2000. Some great initiatives has been implemented by WHO member countries
towards the control of tobacco consumption, an unregulated excessive alcohol intake, and the
global control of diet and nutrition, physical activity and health. A lot of effort has been taken
to reduce potential NCDs as indicated report in the action plan of WHO of 2008-2013 [8-10].
In the sub Saharan Africa regions the reduction of NCDs is not view as a technical resource
issue, but it is a highly political problem which in most cases does not create an enabling health
working environment. The health sectors and the policy-makers in most sub Saharan African
countries are aware of the burden of NCDs, and also the existence of cost-effective interven‐
tions for implementation, unfortunately health intervention policy is not priority [10-12]. So
far, some donors and the international development community have been slow to respond,
in part because NCDs are not among the Millennium Development Goals [11]. So far with all
the repeated donor mobilization and commitments as demonstrated by the Paris Declaration
on Aid Effectiveness and the Accra Agenda for Action, NCDs still receive below 3 % of the
development assistance for health across most countries in sub-Saharan Africa despite the fact
that NCDs are known to cause more than of all premature deaths in these regions [11-14].
The WHO’s Action Plan for the Global Strategy for the Prevention and Control of NCDs has
put in place a strategic health development platform for change and since its adoption in 2008,
a global movement promoted by leaders from developing countries to develop a common
partnership operational platform is effective to some extend [14-16[.The Some partnership
global initiative has led to important decisions like that taken at Doha which led to some
resolution and declarations made on NCDs and different injuries advocating consideration for
integrating the NCD prevention and control into the health management framework [16].
Deliberations at the United Nations Economic and Social Council meeting in July 2009 led to
a United Nations General Assembly Resolution in May 2010, requesting the United Nations
to convene an important meeting in September 2011 inviting the participation of heads of state
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and government [17-18]. Drawing inspiration from the HIV/AIDS crucial meeting in 2001 that
was the turning point in unlocking the HIV epidemic, this meeting also provided an oppor‐
tunity to raise awareness and shift in paradigm in research towards the NCDs within the
framework of the global health development agenda [19-21].
The distribution of the burden f NCDs has shown a big disease gap between the high income
earning countries where the health service is very developed and organized and the low
income countries where the health system is not well organized and less accessible to the poor
subsistence population as shown in Figure 1. There disease burden is more severe with the
highly active population within the age range of 15-59 years recording between 48 %-56 %.
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Figure 1. Disease burden distribution in high income and low income countries (Data source-WHO 2013) [26]
Many efforts have been made to organize important workshops, conferences on NCBs through
the support of Global Health, and stakeholders in health within the WHO mapped sectors,
and in Africa coordinated by the new partnership for Africa (NEPAD), Africa Union support
programmes.
Workshops and consultation forums have contributed towards the production of vital support
documents that serve in the promotion of awareness on NCDs and also important end of meeting
resolution are made through national declaration by the health sector stakeholders that helps
in identifying and targeting strategic areas for possible control intervention. In some develop‐
ing countries efforts have been made towards the creation the health actors’ national pro‐
grammes to deal with NCDs through national consultations and coordination that requires a
high level of commitments from the health stakeholders. There is effort made toward putting
in place a well-developed health monitoring system for sector action evaluation, accountabili‐
ty and participation potential of the NGOs and other affiliated nonpublic health actors, the
public health partnership sectors and to a greater extend efforts made to enhance the strat‐
egies promoting the action plan of established by WHO [22-24]. Resolutions and declarations
form organized symposiums and many organized conferences helps in setting priorities by
policy makers within the WHO member states and a roadmap to put in place sustainable
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implementation strategies. There is the need for the promotion of the awareness and sensitiza‐
tion of NCDs through the outcome of a consultation frame work organized by the health sectors
in the WHO members states, at the level of research institutions, research groups focused on
developing and establishing effective policy and legislation that supports NCDs portfolios [25].
To develop good control strategies for NCDs there is the need for total participation of the
entire public health sectors, actors in health research institutions. The holistic approach
involving the total participation of all stakeholders has shown to be more effective for a
sustainable NCDs in Africa and also support resource poor countries to implement good
control programmes, and channel public health policies towards the intensification of the
prevention action and capacity strengthening for NCDs control and management systems
[24-26]. In the WHO member states where there is well organized structures to support and
promote health professionals leadership and the efforts to promote NCDs management
initiatives, are known to play a significant role in shaping study of the epidemics and managing
the cases of premature deaths in Africa [4, 7, 27]..Some of the main indicators of diseases that
are used such as disease incidence and prevalence, do not give a clear indication when
considering the disease burden involving an individual in a community in poor resource
economy
The unit measure for that is applied to express an indication of the disease burden is known
as the DALY and one DALY which represents the loss of the equivalent of one year of full
health [27]. By using the DALYs, measurement the disease burden involve in early deaths and
little disability such as measles or drowning, could be compared to other diseases that cannot
cause death but has potential to cause disability as the case of cataract that causes blindness
[1, 2, 28-29] NCDs is known to cause about half of the disease burden in the low-and middle-
income countries [22-24], and about one half of the disease burden involves non-communicable
diseases. Among the NCDs Ischaemic heart disease and stroke constitutes the biggest sources
of this disease burden and the cardiovascular diseases account for more than one quarter of
the total disease burden. Currently, injuries have been shown to account for about 17% of the
disease burden in adults aged 15–59 years, within the low- and middle income economies in
Europe, USA and the Eastern Mediterranean Regions, where more than 30% of the entire
disease and injury burden are recorded among men aged between 15–44 years. [29-30].
1.1. Leading causes of burden of disease
Recent studies have shown that the four non-fatal conditions are found in the 20 leading causes
of burden of disease, while the two leading causes of death such as ischaemic heart disease
and cerebrovascular disease, and are among the top six causes of burden of disease as indicated
in table 1. The four primarily non-fatal conditions are also shown to be among the 20 leading
causes of burden of disease; such as hearing loss, alcohol use disorders, and unipolar depres‐
sive disorders to name but a few.. To assess the main causes of loss of health in any populations
it is very relevant to take into consideration the non-fatal conditions as well as deaths. The
income levels are also known to be linked with major differences in burden of disease [3-5].
The two leading causes of burden of disease in the world are infectious diseases such as lower
respiratory infections and diarrheal diseases. HIV/AIDS is known to be the fifth cause of
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burden of disease globally, and three other infectious diseases follows on the top 15 causes as
shown in Table 1.The leading causes of burden of disease in developing nations are very similar
to those recorded globally, with the exception of the statistics for malaria and tuberculosis (TB).
As indicated in Table 1, out of the top ten causes of death, eight belongs to the Group I, however
the leading causes in developed nations are all NCDs, with the exception of road traffic
accidents which is the tenth leading cause of death [29-30].
1.2. The disease and injury burden for women
In a broader perspective depression is now known to be among the leading cause of disease
burden among young adult women with mental disorders that are known as the main source
of lost years of healthy life for women of aged 15–44 years [23].Mental disorders make up three
of the ten leading causes of disease burden in developing countries, and four of the leading
ten in developed countries. Case of self-inflicted injuries have been reported to be among the
leading ten causes for the developing economies [3, 11, and 30]. Injuries have also been shown
to be important for boys beyond infancy, however, the causes of burden of disease are broadly
similar for boys and girls but with, a marked sex differences that is seen between the age range
of 15–59 years. The burden of reproductive problems is generally restricted to developing
nations, and this is vital such that the maternal conditions make up two out of the ten leading
causes of disease burden in women of age groups 15–44 years [29-30]. The HIV/AIDS, and
other maternal conditions are among the main factors contributing to the high disease burden
for women in developing countries with respect to developed countries. In sub Saharan
African and in the South-East Asia regions, the disease burden from maternal conditions is
responsible for about eight percent of the total global disease burden shown in women between
the aged groups of 15–59 year [32-34]. In developing countries great contribution can be made
towards reducing the burden of disease by developing strategies aim at reducing loss of
healthy years that can be enhanced by putting in place better facilities to implement proper
care for pregnant women, promote antenatal and neonatal care, years loss Almost all of this
loss of healthy years of life is avoidable.in low-income countries, better care for women in
pregnancy and childbirth could make a great. The Millennium Development Goal provides
an opportunity for women to have access to a skilled birth attendant during childbirth. This
opportunity where available has reduced to a greater extent the disease burden through the
prevention maternal and neonatal deaths. [9, 35].
1.3. Causes of non-communicable disease
The burden of NCDs are derived from various past and cumulative risks; and the future
burden are now determined by current population exposures to risk factors. Studies have
shown that the major risk factors for NCDs epidemics are more complex than those for
infectious disease and are well known to be responsible for most of such risk factors. [2-6].
Many populations are exposed to the most common groups of NCDs. There are some modi‐
fication of these NCDs within individuals and location but generally the mode of action is the
same worldwide [9-12]. Some determinants on NCD epidemics involves the increase in aging
population, low fertility and the decreasing child survival potential
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The increase in NCDs globally has been caused by a significant change in lifestyle of the
population especially in developing economies. Current trends indicates that more people
spend longer period out of their homes working and eating fast food containing high choles‐
terol level which is a predisposing factor to metabolic diseases, with obvious implication linked
to problems such as low fertility and sexual dysfunction [32-34].
World trade and marketing developments concepts is to orientate the nutrition and food
strategies transition towards diets formulation with a high proportion of saturated fat and
sugars with high cholesterol. The consumption of high cholesterol diet, drug abuse, and
common tobacco use with little or no physical activity can lead to worldwide predisposition
of NCDs [15-17]. In developed countries, seven of the ten leading risk factors contributing to
the burden of disease are for non-communicable disease, compared with six and three of ten
in developing countries with low and high rates of mortality, respectively
1.3.1. Non-communicable disease risk
The NCD risks are higher in developing countries and dominate the disease burden of most
developed  countries,  to  the  extent  that  they  are  considered  as  a  health  priority  in  the
developed  countries  [11,  35].The  developed  countries  have  well-structured  health  pro‐
grammes  to  manage  the  NCD  risks  which  generally  increase  with  age.  It  is  therefore
important  to  develop control  measures  of  the  different  age  distributions  of  populations
through age-standardization of DALY rates, to reduce the apparent NCDs risks. Report on
the age-standardized DALY rates,  are higher in developing countries than in developed
nations [35-37]. This disparity is due mostly to cardiovascular diseases, such as the heart
disease and stroke,  with age standardized burden are significantly higher in developing
nations  than  in  developed  countries.  Other  disease  burden  under  the  group  of  sense
disorders,  vision impairment  and ocular  anomaly like  hearing loss,  is  more common in
developing economies than in the developed countries [35-37].
1.3.2. The Global unequal burden of disease injury
Other reports show that one sixth of the disease burden in adults caused by injuries accounts
for 17% of the disease burden in adults aged between 15–59 years [35-37]. In developing
countries about 30 % of the main disease and injury burden recorded in men between the ages
of 15–44 years are known to result from injuries. In general considering both sexes, road traffic
accidents are the third leading cause of burden in the 15-44 age group that is followed by HIV/
AIDS and unipolar depression. Due to economic decline and poor road infrastructural
development there is a rapid increase in road traffic accidents most especially in the developing
countries [12, 38].The relative importance of intentional injuries varies from regions to regions
and these category of injuries includes aspects like self-inflicted injuries, suicide, violence and
war [37-39]. This type of injury contributes to the increasing rate of the burden, mainly in
economically oriented young adults. In most developed nations, suicides top the cause of
intentional injury burden, while low income economies aspects of violence and war leading
the massive displaced and migratory population are the main cause. Highly politically
unstable regions involve in unrest, civil wars like in the Central Africa sub regions, have rates
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of injury, death and disability among males that are similar to other developing countries [5,
30, and 39]. The death rate resulting from the effect of poisoning is significantly high devel‐
oping countries than in any other region of the world. Consumption of excess and deaths is
also a main cause in developing countries where the unemployment rate is very high and
provokes frustration among the youth. Record of the potential death rate resulting from
injuries cause by fire is significantly higher for women population in the South-East Asia
regions than for the women or men population globally [40].
1.3.3. Global Projection of the burden of disease in 2035
The global forecast for the disease burden per capita is projected to potentially show a decrease
in the global DALYs from 1.53 billion in 2014 to about 1.36 billion in the year 2035, given a
general decrease of approximately 10 % [40-42]. There is also a projection of increase in
population of over 25% during the same time span, which represents a big decrease in the
general per capita disease burden worldwide. The DALY rate general have been shown to
decrease faster than the global death rate due to a potential shift in the chronic NCDs that has
not only occurred in the last decade but has become an economic health issue, that has attained
an epidemic magnitude globally [11, 43-45].
Within the coming years the burden of chronic NCDs is anticipated to be on the increase
particularly in sub Saharan Africa. This projection raises a concern of the potential death of
about 388 million people in the population in the next decade from one or more forms of
CNCDs. This health concern has provoked many states to put in place some action plans
towards reducing a significant number of premature deaths. [21, 46]. There is the possibility
that poor feeding and excessive smoking are two important factors that contribute to the
millions of preventable deaths that occur each year.The CNCDs have a significant negative
economic impact such that looking at the next 1o years, south east Asia, the UK and India are
listed to lose billions in combating the CNCDs.[47-49], Within the framework of globalization,
the increasing interconnection of countries and the openness of borders to ideas, people,
commerce, and financial capital, has beneficial and harmful effects on the health of populations
[2, 14, 50]. The effect of the present current era of globalization on health has to be debated and
reconsidered in a wider perspective [5, 52]. Greater emphasis and interest is now focused on
the control strategies on the infectious diseases and the threats to world security, the supply
of generic drugs and international trade partnership [41, 52].
1.4. The global burden of non-communicable disease and disease injury distribution
Health forecasts projection shows that there are about 56 million deaths globally, of which
about 60 % die as a result of NCDs [53]. 16 million deaths are recorded from cardiovascular
disease (CVD), especially the coronary heart disease (CHD) and stroke; 7 million from cancer;
3 5 million from chronic respiratory disease; and almost 1 million from diabetes [41, 52]. Mental
health problems are known to be the leading cause of disease burden in most countries
irrespective of its state of development and this contribute in many ways to the incidence and
severity of many NCDs such as the cardiovascular disease and cancer [1, 53]. The disease injury
distribution has been grouped into world disease regions of Africa, the Americas, and the
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Eastern Mediterranean and European regions. This distribution are well illustrated in Table
1, showing the disease injury categories and the DALY. It is observed that there is major
variation between these world disease regions.
Disease incidence or injury DALYs
(millions)
Percent
of total
DALYs
Disease or injury DALYs
(millions)
Percent of
total
DALYs
The African sub Regions The Region of the Americas
1 HIV/AIDS diseases 46.7 12.4 1 Unipolar depressive
disorders
10.8 7.5
2 Lower respiratory tract
infections
42.2 11.2 2 Violence abuse 6.6 4.6
3 Diarrheal (gastroenterological
issues
32.2 8.6 3 cardiovascular disease
problems
6.5 4.6
4 Malaria infections-PRD. 30.9 8.2 4 Alcohol abuse disorders 4.8 3.4
5 Neonatal and antenatal
infections and other
13.4 3.6 5 Unstained Road traffic
accidents
4.6 3.2
6 Birth asphyxia and birth
trauma
13.4 3.6 6 Diabetes mellitus 4.1 2.9
7 Premature and low birth
weight
11.3 3.0 7 Cerebrovascular disease 4.0 2.8
8 Tuberculosis problems-PRD 10.8 2.9 8 Lower respiratory
infections
3.6 2.5
9 Road traffic accidents 7.2 1.9 9 Chronic obstructive
pulmonary disorder
COPD
3.1 2.2
10 Protein-energy malnutrition 7.1 1.9 10 Congenital malformation
anomalies
2.9 2.1
The Eastern Mediterranean sub
Regions
The European sub Regions
1 Lower respiratory infection 12.1 8.5 1 Cardiovacular heart
disease
16.8 11.1
2 Diarrheal diseases 8.3 5.9 2 Cerebrovascular disease 9.5 6.3
3 Ischaemic heart disease 6.2 4.3 3 Unipolar depressive
disorders
8.4 5.6
4 Neonatal infections and other 6.1 4.3 4 Alcohol use disorders 5.0 3.3
5 Cot death and birth trauma 5.5 3.9 5 Hearing loss, adult onset 3.9 2.6
6 Premature death and low birth
weight
5.3 3.8 6 Road traffic accidents 3.7 2.4
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Disease incidence or injury DALYs
(millions)
Percent
of total
DALYs
Disease or injury DALYs
(millions)
Percent of
total
DALYs
7 Unipolar depressive disorders 5.2 3.7 7 Trachea, bronchus, lung
cancer
3.3 2.2
8 Road traffic accidents 5.1 3.6 8 Osteoarthritis 3.1 2.1
9 War and conflict problems 3.8 2.7 9 Cirrhosis of the liver 3.1 2.0
10 Congenital malformations 3.7 2.6 10 Self-inflicted injuries 3.1 2.0
The South-East Asia sub Regions The Western Pacific sub Regions
1 Lower respiratory infection 28.3 6.4 1 Cerebrovascular disease 15.8 6.0
2 Diarrheal diseases 23.0 5.2 2 Unipolar depressive
disorders
15.2 5.7
3 Ischaemic heart disease 21..6 4.9 3 COPD 11.9 4.5
4 Unipolar depressive disorders 21.1 4.8 4 Refractive errors 10.6 4.0
5 Prematurity and low birth
weight
18.3 4.1 5 Road traffic accidents 9.6 3.6
6 Neonatal infections and other 14.3 3.2 6 Alcohol use disorders 8.6 3.2
7 Birth asphyxia and birth
trauma
13.9 3.1 7 Ischemic heart disease 7.9 3.0
8 Tuberculosis 12.4 2.8 8 Hearing loss, adult onset 7.0 2.6
9 Road traffic accidents 11.0 2.5 9 Birth asphyxia and trauma 5.7 2.1
10 Cerebrovascular disease 9.6 2.2 10 Tuberculosis 5.6 2.1
COPD, chronic obstructive pulmonary disease PRD-poverty related diseases
Table 1. Global disease injury distribution in the world disease regions of Africa, the Americas, Eastern Mediterranean
region and European Region [13, 29].
There are all indications that communicable diseases in Africa cause more deaths than non-
communicable diseases. NCDs contribute significantly to adult mortality with the highest rates
recorded in central and eastern European sub regions [54]. They increase the problem of health
inequalities within and between affected countries, mainly concerning poor populations due
largely to the inequalities in the distribution of major risk factors [3, 55-56].
2. The effects of globalization on disease burden
The study on economic and financial globalization and the World Trade Organization (WTO)
show that when the national and the international trade is regulated this can lead to improve‐
ment of the health status of the population, although this benefit has little impact in developing
countries [7]. Many countries have put in a lot of efforts towards the regulation of national and
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international trade unfortunately, the limited resources and technical knowhow has not helped
to promote the programme. WTO promotion of drug development and new chemical entities
has enhance the access to many developed pharmaceuticals, but not all countries have same
accessibility due to lack of limited resources. [5, 9]. The development of NCD epidemics where
there are limited access to medical care has been influence to some extend by globalization
[1-3]. The effect of indirect effects of globalization are linked to national economic performance
which act through changes in household income, government spending, and the foreign
exchange, and prices regulation within the different countries [50]. National income play an
important role in health development however in developing countries the resources for health
promotion [51-43]. Some of the drawbacks of globalization on health can be exemplified by
increase in production and commercialization of unfriendly health products such as alcohol,
tobacco and other substances of health abuses readily available to the population. These
commodities unfortunately are very accessible to the population especially in the developing
countries where trade regulation of these products where there exist are difficult to enforce.
[36, 54].
Significant efforts have been made towards the protection of essential local producers in high
income economies and this has had an effect on the management of NCD epidemics. For
instance the move by the European Union (EU) to subsidize agricultural products is aimed at
regulating the competition that may arise from the primary producers. There is little subsidize
unfortunately for fresh produce in low income economies and therefore could reduce the
national income [55]. The EU also subsidize the production of tobacco which has been generally
considered as a policy anomaly because of the negative health effect tobacco has on the
population of consumers. [31, 45, 56]. Some attempts have been made through advocacy for
the removal of the agricultural subsidies and this was endorsed in Doha and then in Johan‐
nesburg during the World Summit on Sustainable Development and most recently the
declaration by the EU gave an indication that the process for lifting subsidies linked to
production is in progress.
Modern information and communication technologies (ICT) have been shown to have some
positive and negative effects on health. It is evident that global commercialization of products
like tobacco, alcohol, and other essential household products could be made available to all
parts of the country ICT has made it possible for global commercialization shifting market
target to the younger population [3, 11]. In the USA for example millions of dollars are put
into persuasive marketing that has encourage young people to develop interest in fast food
with high cholesterol content, fizzy drinks, alcohol and tobacco. The power of media publicity
and advertisements through the use of more sophisticated technology has promoted the
persuasive marketing and also exploiting the poor regulatory environment to capture and
penetrate the consumer market [21-26].
2.1. Globalization, nutrition and alcohol on disease burden
Nowadays there has been a great substitution of our natural organic traditional food rich in
fruit, vegetables and fibers by diets rich in calories from animal fats and low in complex
carbohydrates. The impact of this food substitution syndrome has had more impact in
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developing countries [3. 11, 17]. Such changes has led to an increased rates of many NCDs in
countries previously protected by balanced and healthy diets. Sub-Saharan Africa, Asia and
some South American countries are undergoing a big shift in consumption patterns, and
consumer life style transformation although rates of heart disease are still low compared to
developed countries, and stroke rates have also reduced significantly in countries like
Singapore and Japan [46]..
Globally there has been a steady increase transformation in farming [45] food processing,
distribution [23] transportation [19] shopping practices [3, 55] and the consumption of food
outside of the home (fast food, take away) [27]. Cooking has changed with the development of
microwave, ovens and other techniques and changing lifestyles, especially in the urban cities
where people work long hours out of home [14]. Changing patterns of production and
consumption underlie the emergence of NCD epidemics and poses a problem to achieving a
sustainable development goals [56]. The impact of alcohol consumption in promoting non-
communicable disease epidemics has become very complex and a significant correlation has
been shown between alcohol consumption and liver cirrhosis, some cancers, and most causes
of injuries and violence. Alcohol also enhances and predispose the population to the risk of
cardiovascular disease [22, 36].
2.2. Global policies towards non-communicable disease control strategy
2.2.1. Prevention strategy
The progression of non-communicable disease, especially lung cancer in men and CVD, have
reduced significantly in many developed countries than in low income economies. For
example in lung cancer, the reduction in mortality is linked to the concerted prgramme
developed to reduce tobacco consumption by the population [50-52]. There are indications
that, in many European countries, and south East Asia lung cancer epidemics is on the increase
especially in women. This increase is linked to the rise in smoking habit developed in women
and the lack of traditional health promotion programmes to enhance regulation of tobacco
marketing strategies oriented towards young women [9]. The cause of reduction in CVD
mortality are complex but are linked to improved management in high risk people, in
particular in the USA, and in some countries, such as Finland and Sweden, where there are
prevention programmes aimed at reducing the risk levels in combination with other environ‐
mental changes within the population [46].
The application of existing knowledge could play a major, rapid, and cost-effective contribu‐
tion to the prevention and control of NCD epidemics [18]. The agenda of most international
donors is focused on belief that communicable diseases can be prevented or treated before
addressing the problems of NCDs [45]. The report made by the Commission on Macroeco‐
nomics and Health did not consider as a priority to make any emphasis or awareness on the
importance of the growing burden of NCDs [7], this is probably because of the misconception
that NCDs are still the preserve of wealthy countries and populations. Generally in developing
countries the institutional response to disease prevention and control is still based on the
infectious disease paradigm [15, 34].and therefore the global and national ability in managing
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non-communicable disease epidemics is very inadequate and few countries have successfully
put in place a workable prevention and control programmes [1, 16].
2.2.2. Global advocacy for non-communicable disease
The sensitization and active advocacy is still at its infancy at the global level for NCD preven‐
tion and control [8], and even the control platforms developed in advanced countries are still
not well coordinated to highlight the risk-factor or disease specificity [53]. The lack of coordi‐
nation between evidence and action in the for example in USA can also be applied globally
[25]. Many potential advocacy groups have their origins in specialist organizations of health
professionals, and are not coordinated to generate a force as powerful promoters of broad
prevention and control policies [16, 35]. This lack of advocacy for health promotion is not in
line with the expanding commercial and consumer groups who have placed treatment at the
centre of health policy debates and funding priorities [31].A powerful widely coordinated
health alliances are necessary for main health professional organizations, consumer groups,
corporate industries, and research institution to effectively manage the prevention of major
risk factors for NCDs [14, 54].All efforts to promote research to address challenges in chronic
non communicable diseases prevention, control are being promoted through research
initiatives and stake holder funding opportunities. These challenges and the study research
needs have been addressed in table 2.
Major challenges Study/Research needed to address goals
Goal A
Sensitization/
Advocacy
Increase the political priority of NCD
Encourage healthy lifestyle and consumers
choices through effective sensitization
advocacy and public engagement
sensitization
Assemble valid information for widespread
media coverage and sensitization of
economic, social and public health
programmes
Engaging stakeholders in partnership for disease
prevention
How to create public forums to raise awareness of
issues relating to chronic NCDs
Promote research platform for health involving the
government some state sectors such as the health
eduction and environment, transportation
Research the causes for poor sensitization and
promoting awareness to chronic disease in the
community.
Goal B
Advancing
economic
legal and
environmental
policies
The effect of poor health on economic output
and productivity
The effect State spending and taxation on
health
System to implement local, national and
international policies with trade regulation
policies on health related consumer
products.
Quantify impact of chronic NCDs on local
economies
Program on the international implication of changes
in health related food consumption
Assess motivations associated with domestic
spending, and changing lifestyle choices
study the health effect of agriculture, climate change
and policy interventions
Research on health and economic effects of
developed community-based interventions
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Major challenges Study/Research needed to address goals
Setting up population metrics, health indicators
program for policy and programme surveillance
Research on the efficiency of food-labeling
legislation and policies
Goal C
Programme
management of
possible
risk factors
Knowledge of environmental and cultural
factors linked to social behavior changes
Enforcement of sustainable programmes to
minimize tobacco consumption
Promote healthy food intake in the
population
Develop sustainable physical activity
strategic programmes
Study behavioral modifications to reduce risks
Study risk factors, and the factors associated or
affect risk in chronic NCDs.
Study new medical products for the prevention of
heart disease and diabetes
Study the socio-cultural, ethnic and genetic
diversity linked to risk factors that support
behavioral interventions
Assess personal risk linked to phenotypes,
genotypes and multiple risks factors
Evaluate genotype by environment interaction of
environment of genes in risk factors and the
outcomes
Research on new biomarkers and diagnostics for
risk and early disease diagnosis.
Goal D
Participation in
community outreach
Application of business models as main tool
to sensitize health and preventable disease
Develop business ethics and code of conduct
for the food ndustries
Enhance community resources such as
voluntary and NGOs
Study marketing techniques and marketing data
resulting from commercial firms on behavioral
patterns.
Investigate the mechanisms for consumers and the
public have a positive influence on the food
industry
Research the impact of taste, packaging, labeling
and advertising on choice and health of consumers.
Create and evaluate community-based strategies to
promote healthy living
Source the method of effective public-private
partnerships to support health
Goal E
Identification the
health impacts on
poverty and
urbanization
Study and address how poverty increases
risk factors
Study and address the links between
urbanization and chronic NCD
Assess the relationship between poverty and the
risk associated to health
Examine the influence of poverty on the adoption of
high-risk behavior
Identify negative effects of economic growth on
health
Study the importance in town planning to promote
the environment on healthy living
Goal F Strategies to mobilize resources in health
systems in function of the disease burden.
Develop strategies that can incorporate a
sustainable health-system control/prevention of
non-communicable diseases
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Major challenges Study/Research needed to address goals
Reorientation of the
health system
platforms
Direct capacity building of health
professional within prevention management,
Increase number and skills of professionals
in prevention and controlof chronic non-
communicable diseases
Built health systems that integrate screening
and prevention within health delivery
Increase access to medication to prevent
complications of chronic non-communicable
diseases
Develop partnership work platforms to promote
best practices in delivering accessible, cheap health
care
Research on ways in supporting an organized
education on health promotion
Put in place roadmap for the promotion of health
training and development of courses targeted on
chronic non-communicable diseases
Provide local technical knowhow to enhance the
training of health personnel
Evaluate effective methods to promote optimal
resources distribution of health care in poor
communities
Promote and advocate the use of e-health records in
disease forecasting
Investigate effective means of developing practical
health surveillance tools.
Implementation of high throughput screening
mechanism that group the population according to
health disease predisposition risk factors.
Table 2. Global Challenges in chronic NCDs and advocacy tools for research needs [10, 53].
2.3. Partnerships collaboration for addressing disease burden
The challenges of non-communicable disease are so complex that there is a need for many
stakeholders to collaborate in developing a control strategy. For improve the quality and
regular access to quality healthy food, there is a need for a meaningful partnership collabora‐
tion between producers the consumer groups and the multinational food companies [13, 37].
The WHO has effectively developed a working to handle diet and physical activities with
respect to the chronic diseases. This collaborative approach has seen the development of food
regulatory guidelines, effective consultations process between WHO, the state, consumer
groups, and many companies. Many food producing companies have reported the changes
that is occurring in product labelling to reduce competition and promote marketing practices;
if widely implemented, these changes could lead to significant benefits of globalization
support to public health [40]. Other participatory partnership involving WHO involves
working in close collaboration with the people and promote safe alcohol consumption.
2.4. Building Capacity and resources platforms for non-communicable disease management
Strengthening capacity for NCDs management is very important and must be promoted
especially in low income economies where health information system management are not
well developed. [20, 26].Other constraints in building good resource platforms for NCDs is the
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slow institutional response to capacity strengthening, lack of vision and mission not align
epidemiological survey activities. There is a need for creating an enabling environment for
important financial commitment in different countries that may vary depending on the
strategic planning programme put in place to build capacities that can plan and manage
activities towards combating diseases and sustainable health of the population [9]. There are
many initiatives at the national and international level to develop policies and working
documents for NCDs management within the framework of public health sectorial health
development portfolio, to what extend thses policies are effective can only be known when
there is marked improvement or continuous increase in the management of patient health
within a define country or jurisdiction.[15, 29].There has been a significant progress in building
or promoting research partnership or collaboration by researchers at institutional, national and
international level, a global advocacy for NCDs that has attracted some funding by potential
donors in the health sector [53] There has been a significant progress made by international
consortiums to support investment towards tobacco control research by building institutional
research platforms in some developing countries and this is also being extended to other
aspects of non-communicable diseases.
3. Global norms and standards in the management of chronic non-
communicable diseases
In other to achieve success in NCDs management initiatives there must be respect for inter‐
national standard norms and ethics regulating the health sector.
Each country needs to develop initiative to train health personnel’s on international ethical
code of conduct guiding or regulating clinical research for diseases affecting the population
and the global trade regulatory issue of health related products [5, 53], The respect of ethical
norms in the health sectorial research and development is still not a standard practice in the
management of NCDs in developing countries.. Despite the creation of ethical committees and
institutional review boards to regulate clinical research there are still problems that are linked
to nutrition and lack of physical activity that are difficult to address.
Multi stakeholder and other state policies are initiatives geared towards the sensitization and
advocacy to regulate the consumption and sales of food and alcohol especially for the younger
population [11].
3.1. Reorientation of health services towards management of non-communicable disease
There has been significant increase in premature loss of lives as a result the lack of a sustainable
management system for the control and prevention of NCDs. In some developed countries
well developed and user-friendly intervention systems are available for CVD management
and these are now successfully transferred to some privileged developing countries to support
interventions in CVDs [30]. There has been a significant global initiative to develop an effective
disease management system for cancer therapy. This system has contributed significant on the
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ease of diagnostics, the prevention and treatment and methods for procedures for palliative
has also improved. [11, 21, 53]. Considering for example NCD like the of breast cancer and
cervical cancer, that has also become a serious health concern in sub Saharan African countries,
among women of child bearing age, there is no proper sensitization mechanism about the
threat of this disease and the health implication for young child bearing women. In addition
diagnostic tools and procedures are not well developed, and in most cases diagnostics are
made only when severe cases are reported at the late stage of cancer at the hospitals, health
districts or integrated health centres. In most countries of the central Africa sub regions the
states has made a lot of effort to fight against cancer by creating health committee at the
ministry of health, and a society for cancer research. Despite these initiative by the government
the impact is not felt at the rural areas. Activities by some NGOs or other operational bodies
is focused in the cities. There are many opportunities for coordinated non-communicable
disease risk reduction, care, and long-term management.
4. Conclusion
The advancement of globalization of the major risks for non-communicable diseases is on a
steady increase especially in resource countries plague with poverty, political and economic
instability. On the other hand, the prospects for non-communicable chronic disease diagnosis,
prevention and management and control is still generally at its infancy. We can attain a
sustainable progress when the governments, stakeholders of international agencies, non-
governmental agencies, and civil society create an enabling environment and acknowledge
the integration of non-communicable disease as a risk factor in the public health agenda. The
challenges are enormous and the fight to promote healthy food consumption and maintenance
of a healthy lifestyle towards reducing metabolic diseases or lifestyle diseases, like diabetes,
hypertension, CVD will remain slow until the response or taskforce to NCD epidemics is well
developed and structured to meet up with their disease burden. The advocacy and the
importance of sensitization of the global community on the importance of non-communicable
disease as a public health concern is no longer the responsibility of WHO but a global mobi‐
lization of nations, donors, stakeholder and greater promotion and encouragement of research
funding opportunities. Advocacy for NCDs has gain so much priority of recent in the public
health strategic disease prevention and control in most in Africa to the extent that in Cameroon
and its Central African states there has been national and sub-regional consortium for the
management of NCDs.
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